Association between hospital recognition for nursing excellence and outcomes of very low-birth-weight infants.

JAMA

Center for Health Outcomes and Policy Research, School of Nursing, Department of Sociology, and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, PA 19104-6096, USA.

Published: April 2012

AI Article Synopsis

  • Infants born with very low birth weight (VLBW) need intense care, and this study investigates how nursing excellence (recognized through specific awards) impacts their health outcomes in the U.S.
  • The study analyzed data from over 72,000 VLBW infants in 558 hospitals, focusing on mortality rates and infections within specific time frames post-birth.
  • Results indicated lower rates of 7-day and 28-day mortality, hospital stay mortality, severe intraventricular hemorrhage, and infections in hospitals recognized for nursing excellence compared to those that were not.

Article Abstract

Context: Infants born at very low birth weight (VLBW) require high levels of nursing intensity. The role of nursing in outcomes for these infants in the United States is not known.

Objective: To examine the relationships between hospital recognition for nursing excellence (RNE) and VLBW infant outcomes.

Design, Setting, And Patients: Cohort study of 72,235 inborn VLBW infants weighing 501 to 1500 g born in 558 Vermont Oxford Network hospital neonatal intensive care units between January 1, 2007, and December 31, 2008. Hospital RNE was determined from the American Nurses Credentialing Center. The RNE designation is awarded when nursing care achieves exemplary practice or leadership in 5 areas.

Main Outcome Measures: Seven-day, 28-day, and hospital stay mortality; nosocomial infection, defined as an infection in blood or cerebrospinal fluid culture occurring more than 3 days after birth; and severe (grade 3 or 4) intraventricular hemorrhage.

Results: Overall, the outcome rates were as follows: for 7-day mortality, 7.3% (5258/71,955); 28-day mortality, 10.4% (7450/71,953); hospital stay mortality, 12.9% (9278/71,936); severe intraventricular hemorrhage, 7.6% (4842/63,525); and infection, 17.9% (11,915/66,496). The 7-day mortality was 7.0% in RNE hospitals and 7.4% in non-RNE hospitals (adjusted odds ratio [OR], 0.87; 95% CI, 0.76-0.99; P = .04). The 28-day mortality was 10.0% in RNE hospitals and 10.5% in non-RNE hospitals (adjusted OR, 0.90; 95% CI, 0.80-1.01; P = .08). Hospital stay mortality was 12.4% in RNE hospitals and 13.1% in non-RNE hospitals (adjusted OR, 0.90; 95% CI, 0.81-1.01; P = .06). Severe intraventricular hemorrhage was 7.2% in RNE hospitals and 7.8% in non-RNE hospitals (adjusted OR, 0.88; 95% CI, 0.77-1.00; P = .045). Infection was 16.7% in RNE hospitals and 18.3% in non-RNE hospitals (adjusted OR, 0.86; 95% CI, 0.75-0.99; P = .04). Compared with RNE hospitals, the adjusted absolute decrease in risk of outcomes in RNE hospitals ranged from 0.9% to 2.1%. All 5 outcomes were jointly significant (P < .001). The mean effect across all 5 outcomes was OR, 0.88 (95% CI, 0.83-0.94; P < .001). In a subgroup of 68,253 infants with gestational age of 24 weeks or older, the ORs for RNE for all 3 mortality outcomes and infection were statistically significant.

Conclusion: Among VLBW infants born in RNE hospitals compared with non-RNE hospitals, there was a significantly lower risk-adjusted rate of 7-day mortality, nosocomial infection, and severe intraventricular hemorrhage but not of 28-day mortality or hospital stay mortality.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640284PMC
http://dx.doi.org/10.1001/jama.2012.504DOI Listing

Publication Analysis

Top Keywords

rne hospitals
32
non-rne hospitals
24
hospitals adjusted
24
hospital stay
16
stay mortality
16
hospitals
14
rne
12
7-day mortality
12
28-day mortality
12
severe intraventricular
12

Similar Publications

Background: The timing of a breast cancer (BC) diagnosis has a significant psychological impact on patients. However, it reported that those eligible for treatment regimens based on neoadjuvant chemotherapy may experience high levels of depression, anxiety and distress. To cope with this situation, patients deploy psychological coping strategies.

View Article and Find Full Text PDF

Psychological distress and coping strategies in breast cancer patients under neoadjuvant therapy: A systematic review.

Womens Health (Lond)

September 2024

Laboratory of Epidemiology and Research in Health Sciences, Faculty of Medicine, Pharmacy and Dental Medicine, Sidi Mohamed Ben Abdallah University, Fez, Morocco.

Article Synopsis
  • - The study explores psychological distress (PD) and coping strategies in patients undergoing neoadjuvant therapy (NAT) for locally advanced breast cancer (LABC), finding a significant prevalence of depression and anxiety both before and after treatment.
  • - Results indicate that PD can decrease during NAT, and factors such as social support and living conditions play a role in patients' mental health; also, the effectiveness of coping strategies shifted, with "resigned coping" decreasing while "social support" increased post-treatment.
  • - Interventions like mobile health apps, diet changes, and relaxation techniques showed promise in reducing PD, emphasizing the need for psychological support throughout the treatment process for LABC patients.
View Article and Find Full Text PDF

In this study, active and intelligent films were fabricated using . starch (MES), gum ghatti (GG) and . extract (RNE) and their functionality, physicochemical properties and practical application were assessed.

View Article and Find Full Text PDF

This research aimed to assess the potential of active food packaging as an innovative approach to enhance the quality of fresh food products. Specifically, our focus was on developing chitosan edible films combined with rosemary nanoemulsion (Ch-RNE) and carvacrol nano-emulsion (Ch-CNE) as effective antibacterial food packaging solutions. The efficacy of these films against artificially inoculated L.

View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed trends of bloodstream infections (BSI) caused by Enterococcus spp. in adult patients at German tertiary care centers from October 2016 to June 2020, finding a significant increase in cases over this period.
  • - Among 3001 identified patients, E. faecium was the most prevalent species (61%), and the study revealed a concerning rise in vancomycin-resistant enterococci (VRE), which accounted for more than 12% of cases by 2020.
  • - The increase in VRE BSI is linked to factors like prior antibiotic use and invasive procedures, emphasizing the need for better treatment options due to the high mortality associated with these infections.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!